2m 2m 2m 2m 2m 2m 2m
Akso Health Sp ADR (AHG)
NASDAQ
$1.42-$0.15 (-9.55%)
Price as of Aug 03, 2026 3:24 PM EDT- $1.3BMarket Cap
- -8.19%1-Year Change
- Medical DistributionIndustry
Akso Health Sp ADR (AHG)
$1.42-$0.15 (-9.55%)
Annual
Quarterly
03/31/2026 | 03/31/2025 | 03/31/2024 | 03/31/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | 14.8M +512.08% | 2.4M -81.68% | 13.2M +108.86% | |
Cost of Revenue | 13.8M -8.08% | 15.1M +556.98% | 2.3M -80.76% | 11.9M +120.81% | |
Gross Profit | -11,315 -95.98% | -281,526 -330.51% | 122,132 -90.38% | 1.3M +38.50% | |
Sales and Marketing Expense | 4.0M +9.54% | 3.6M +2,062.11% | 168,421 +2,428.46% | 6,661 -97.24% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 2.4M +10.32% | 2.1M N/A | N/A N/A | N/A N/A | |
Total Operating Expenses | 20.7M -87.54% | 166.0M +1,795.20% | 8.8M -43.61% | 15.5M -7.82% | |
Operating Profit | -20.7M -87.55% | -166.3M +1,825.26% | -8.6M -39.45% | -14.3M -10.48% | |
Interest Income | 344 -99.27% | 47,091 -81.34% | 252,408 -83.60% | 1.5M +3,673.48% | |
Interest Expense | N/A N/A | N/A N/A | -27 N/A | N/A N/A | |
Interest Income and Expense and Net | 344 -99.27% | 47,091 -81.34% | 252,381 -98.04% | 12.9M +1,639.41% | |
Total Nonoperating Income and Expense | -4,113 -112.07% | 34,073 +107.51% | -453,751 -137.80% | 1.2M +253.79% | |
Income before Taxes | -20.7M -87.55% | -166.3M +1,728.80% | -9.1M -30.42% | -13.1M -21.84% | |
Income Taxes | -2.0M -93.54% | -30.8M -123,363.75% | 24,988 +42.39% | 17,549 -86.65% | |
Extraordinary Items | 5.6M -95.35% | 121.1M N/A | N/A N/A | N/A N/A | |
Net Income | -18.7M -86.13% | -135.0M +1,327.01% | -9.5M +595.54% | -1.4M -91.93% | |
Net Income from Continuing Operations Applicable to Common | -18.7M -86.18% | -135.5M +1,385.93% | -9.1M -30.32% | -13.1M -21.74% | |
Basic EPS and Net Income | 0.01 +106.25% | -0.16 +128.57% | -0.07 +250.00% | -0.02 -92.86% | |
Diluted EPS and Net Income | 0.01 +106.25% | -0.16 +128.57% | -0.07 +250.00% | -0.02 -92.86% | |
Basic Weighted Average Shares | 2.2B +153.50% | 855.3M +504.37% | 141.5M +106.30% | 68.6M +15.07% | |
Diluted Weighted Average Shares | 2.2B +153.50% | 855.3M +504.37% | 141.5M +106.30% | 68.6M +15.07% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 170,572 -99.90% | 176.2M +106.91% | 85.2M +974.82% | 7.9M -63.86% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 170,572 -99.90% | 176.2M +106.91% | 85.2M +974.82% | 7.9M -63.86% | |
Total Current Assets | 189.5M -3.35% | 196.1M +38.10% | 142.0M +594.12% | 20.5M -59.58% | |
Accumulated Depreciation | 8,354 +418.24% | 1,612 N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 12,015 -25.59% | 16,148 N/A | N/A N/A | N/A N/A | |
Total Long-Term Assets | 12,015 -99.94% | 18.8M -30.18% | 27.0M +93,870.03% | 28,698 -48.23% | |
Total Assets | 189.6M -11.78% | 215.0M +51.36% | 142.0M +594.12% | 20.5M -59.63% | |
Income Taxes Payable | 93,284 -95.29% | 2.0M +2,574.37% | 74,091 -22.83% | 96,005 -23.29% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 8.7M -36.95% | 13.8M +284.34% | 3.6M -69.07% | 11.6M -69.73% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 2,565 -99.87% | 2.0M -99.31% | 290.2M N/A | N/A N/A | |
Total Liabilities | 8.7M -44.87% | 15.8M +339.69% | 3.6M -69.07% | 11.6M -69.73% | |
Retained Earnings | -217.6M +9.39% | -198.9M +211.15% | -63.9M +17.37% | -54.5M +2.56% | |
Total Stockholders Equity | 180.9M -9.13% | 199.1M +43.91% | 138.4M +1,485.82% | 8.7M -28.97% | |
Total Shares Outstanding | 2.6B +54.76% | 1.7B +278.70% | 437.2M +537.29% | 68.6M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | -12.8M -1,186.62% | 1.2M -12.88% | 1.4M +141.53% | -3.3M -62.29% | |
Capital Expenditures | 1,638 -98.94% | 154,460 N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -163.5M +54.34% | -105.9M +93.55% | -54.7M -396.25% | 18.5M +192.52% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 350,000 -99.82% | 195.9M +48.79% | 131.7M +578.50% | -27.5M -179.11% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | -1.91% -137.66% | 5.06% -47.45% | 9.63% -33.69% | |
Operating Margin | N/A N/A | -1,125.37% +214.54% | -357.78% +230.56% | -108.23% -57.14% | |
Return on Assets | -9.25% -87.77% | -75.62% +549.51% | -11.64% +204.54% | -3.82% -90.66% | |
Return on Equity | -9.85% -87.69% | -79.99% +521.96% | -12.86% -0.66% | -12.95% -88.65% | |
Revenue Growth | N/A N/A | 512.08% +726.91% | -81.68% -175.03% | 108.86% -58.07% | |
Current Ratio | 21.77 +53.29% | 14.20 -64.07% | 39.52 +2,144.35% | 1.76 +33.54% | |
Cash Ratio | 0.02 -99.85% | 12.76 -46.17% | 23.70 +3,375.51% | 0.68 +19.40% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow